ÜSKÜDAR CANSU, D. Et Al. 2014. Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug?. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.2 , 62-66.

ÜSKÜDAR CANSU, D., Guncan, S., Bilge, N. Ş., KAŞİFOĞLU, T., & KORKMAZ, C., (2014). Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug?. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.2, 62-66.

ÜSKÜDAR CANSU, DÖNDÜ Et Al. "Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug?," EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.2, 62-66, 2014

ÜSKÜDAR CANSU, DÖNDÜ Ü. Et Al. "Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug?." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.2, pp.62-66, 2014

ÜSKÜDAR CANSU, D. Et Al. (2014) . "Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug?." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.1, no.2, pp.62-66.

@article{article, author={DÖNDÜ ÜSKÜDAR CANSU Et Al. }, title={Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug?}, journal={EUROPEAN JOURNAL OF RHEUMATOLOGY}, year=2014, pages={62-66} }